Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
Submitted by
admin
on September 4, 2008 - 8:26am
Source:
Yahoo/AP
Headline:
ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
Do Not Allow Advertisers to Use My Personal information
